{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:31:13Z","timestamp":1790753473130,"version":"4.1.0"},"reference-count":35,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2004,7,20]],"date-time":"2004-07-20T00:00:00Z","timestamp":1090281600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2004,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The present study aimed to determine whether rapamycin could increase the expression of <jats:italic>\u03b3<\/jats:italic>\u2010globin genes in human erythroid cells. Rapamycin is a macrocyclic lactone that possesses immunosuppressive, antifungal and anti\u2010tumour properties. This molecule is approved as an immunosuppressive agent for preventing rejection in patients receiving organ transplantation. To verify the activity of rapamycin, we employed two experimental cell systems, the human leukaemia K562 cell line and the two\u2010phase liquid culture of human erythroid progenitors isolated from normal donors and patients with <jats:italic>\u03b2<\/jats:italic>\u2010thalassaemia. The results suggested that rapamycin, when compared with cytosine arabinoside, mithramycin and cisplatin, is a powerful inducer of erythroid differentiation and <jats:italic>\u03b3<\/jats:italic>\u2010globin mRNA accumulation in human leukaemia K562 cells. In addition, when normal human erythroid precursors were cultured in the presence of rapamycin, <jats:italic>\u03b3<\/jats:italic>\u2010globin mRNA accumulation and fetal haemoglobin (HbF) production increased to levels that were higher than those obtained using hydroxyurea. These effects were not associated with inhibition of cell growth. Furthermore, rapamycin was found to increase HbF content in erythroid precursor cells from four <jats:italic>\u03b2<\/jats:italic>\u2010thalassaemia patients. These results could have practical relevance, because pharmacologically mediated regulation of the expression of human <jats:italic>\u03b3<\/jats:italic>\u2010globin genes, leading to increased HbF, is considered a potential therapeutic approach in haematological disorders, including <jats:italic>\u03b2<\/jats:italic>\u2010thalassaemia and sickle cell anaemia.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2004.05083.x","type":"journal-article","created":{"date-parts":[[2004,7,30]],"date-time":"2004-07-30T13:37:00Z","timestamp":1091194620000},"page":"612-621","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Rapamycin\u2010mediated induction of <i>\u03b3<\/i>\u2010globin mRNA accumulation in human erythroid cells"],"prefix":"10.1111","volume":"126","author":[{"given":"Carlo","family":"Mischiati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Sereni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Lampronti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Borgatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Prus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eitan","family":"Fibach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Gambari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,7,20]]},"reference":[{"key":"e_1_2_15_2_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01173.x"},{"key":"e_1_2_15_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(00)00297-5"},{"key":"e_1_2_15_4_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02843.x"},{"key":"e_1_2_15_5_1","first-page":"826","article-title":"Induction of gamma\u2010globin gene expression by tallimustine analogs in human erythroid cells","volume":"88","author":"Chiarabelli C.","year":"2003","journal-title":"Haematologica"},{"key":"e_1_2_15_6_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.16.11.6242"},{"key":"e_1_2_15_7_1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/blood.V73.1.100.100","article-title":"Proliferation and maturation of human erythroid progenitors in liquid medium","volume":"73","author":"Fibach E.","year":"1989","journal-title":"Blood"},{"key":"e_1_2_15_8_1","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1182\/blood.V81.6.1630.1630","article-title":"Hydroxyurea increases fetal hemoglobin in cultured erythroid cells derived from normal individuals and patients with sickle cell anemia or beta\u2010thalassemia","volume":"81","author":"Fibach E.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_15_9_1","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1182\/blood.V82.7.2203.2203","article-title":"Enhanced fetal hemoglobin production by phenylacetate and 4\u2010phenylbutyrate in erythroid precursors derived from normal donors and patients with sickle cell anemia and \u03b2\u2010thalassemia","volume":"82","author":"Fibach E.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_15_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3096"},{"key":"e_1_2_15_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0045-6039(84)90033-2"},{"key":"e_1_2_15_12_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.887201"},{"key":"e_1_2_15_13_1","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1681\/ASN.V1061366","article-title":"Newer immunosuppressive drugs: a review","volume":"10","author":"Gummert J.F.","year":"1999","journal-title":"Journal of the American Society of Nephrology"},{"key":"e_1_2_15_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(96)00044-5"},{"key":"e_1_2_15_15_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.011511898"},{"key":"e_1_2_15_16_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2003.00113.x"},{"key":"e_1_2_15_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(00)00654-8"},{"key":"e_1_2_15_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309163291205"},{"key":"e_1_2_15_19_1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood.V45.3.321.321","article-title":"Human chronic myelogenous leukemia cell\u2010line with positive Philadelphia\u2010chromosome","volume":"45","author":"Lozzio C.B.","year":"1975","journal-title":"Blood"},{"key":"e_1_2_15_20_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200140080-00002"},{"key":"e_1_2_15_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1998.tb10467.x"},{"key":"e_1_2_15_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199301143280202"},{"key":"e_1_2_15_23_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2000.90032.x"},{"key":"e_1_2_15_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0268-960X(94)90109-0"},{"key":"e_1_2_15_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb05288.x"},{"key":"e_1_2_15_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199301143280201"},{"key":"e_1_2_15_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/280164a0"},{"key":"e_1_2_15_28_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.00460.x"},{"key":"e_1_2_15_29_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00719.x"},{"key":"e_1_2_15_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)00117-3"},{"key":"e_1_2_15_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(03)00211-2"},{"key":"e_1_2_15_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199506153322404"},{"key":"e_1_2_15_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.3.1078"},{"key":"e_1_2_15_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-437X(98)80095-6"},{"key":"e_1_2_15_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(01)00626-9"},{"key":"e_1_2_15_36_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.835000"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2004.05083.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2004.05083.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2004.05083.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T23:31:43Z","timestamp":1697412703000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2004.05083.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,20]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["10.1111\/j.1365-2141.2004.05083.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2004.05083.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,20]]},"assertion":[{"value":"2004-07-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}